Glaukos (GKOS) EBIAT (2016 - 2025)
Glaukos (GKOS) has disclosed EBIAT for 12 consecutive years, with -$133.7 million as the latest value for Q4 2025.
- On a quarterly basis, EBIAT fell 298.05% to -$133.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$187.7 million, a 28.23% decrease, with the full-year FY2025 number at -$187.7 million, down 28.23% from a year prior.
- EBIAT was -$133.7 million for Q4 2025 at Glaukos, down from -$16.2 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $6.2 million in Q3 2021 to a low of -$133.7 million in Q4 2025.
- A 5-year average of -$30.9 million and a median of -$29.0 million in 2022 define the central range for EBIAT.
- Peak YoY movement for EBIAT: surged 139.56% in 2021, then crashed 743.97% in 2023.
- Glaukos' EBIAT stood at -$21.9 million in 2021, then tumbled by 43.84% to -$31.5 million in 2022, then decreased by 16.91% to -$36.8 million in 2023, then rose by 8.7% to -$33.6 million in 2024, then plummeted by 298.05% to -$133.7 million in 2025.
- Per Business Quant, the three most recent readings for GKOS's EBIAT are -$133.7 million (Q4 2025), -$16.2 million (Q3 2025), and -$19.7 million (Q2 2025).